BRKR (STOCKS)
Bruker Corporation
$57.930000
-1.340000 (-2.26%)
Prev close: $59.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Frank H. Laukien
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8,826.16M
- Employees
- 11,396
- P/E (TTM)
- -84.26
- P/B (TTM)
- 3.79
- Dividend Yield
- 33.74%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.50B |
| Benefits Costs and Expenses | $3.52B |
| Cost Of Revenue | $1.88B |
| Costs And Expenses | $3.52B |
| Gross Profit | $1.62B |
| Nonoperating Income/Loss | $8.20M |
| Operating Expenses | $1.66B |
| Selling, General, and Administrative Expenses | $970.70M |
| Research and Development | $393.50M |
| Other Operating Expenses | $290.80M |
| Operating Income/Loss | -$30.60M |
| Income/Loss From Continuing Operations After Tax | -$62.80M |
| Income/Loss From Continuing Operations Before Tax | -$22.40M |
| Income Tax Expense/Benefit | $40.40M |
| Income Tax Expense/Benefit, Deferred | -$97.00M |
| Net Income/Loss | -$64.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $6.70M |
| Net Income/Loss Attributable To Parent | -$71.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$106.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $35.70M |
| Preferred Stock Dividends And Other Adjustments | $35.70M |
| Basic Earnings Per Share | -$0.70 |
| Diluted Earnings Per Share | -$0.70 |
| Basic Average Shares | 456,400,000 |
| Diluted Average Shares | 456,900,000 |
| Assets | $6.05B |
| Current Assets | $2.23B |
| Inventory | $1.12B |
| Prepaid Expenses | $46.60M |
| Other Current Assets | $1.06B |
| Noncurrent Assets | $3.83B |
| Fixed Assets | $714.10M |
| Other Non-current Assets | $3.11B |
| Liabilities | $3.65B |
| Current Liabilities | $1.20B |
| Accounts Payable | $200.20M |
| Other Current Liabilities | $1.00B |
| Noncurrent Liabilities | $2.45B |
| Long-term Debt | $1.82B |
| Other Non-current Liabilities | $623.20M |
| Redeemable Noncontrolling Interest | $35.60M |
| Equity | $2.40B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.40B |
| Temporary Equity | $35.60M |
| Liabilities And Equity | $6.05B |
| Net Cash Flow From Operating Activities | $190.40M |
| Net Cash Flow From Operating Activities, Continuing | $190.40M |
| Net Cash Flow From Investing Activities | -$144.30M |
| Net Cash Flow From Investing Activities, Continuing | -$144.30M |
| Net Cash Flow From Financing Activities | $35.10M |
| Net Cash Flow From Financing Activities, Continuing | $35.10M |
| Exchange Gains/Losses | $11.70M |
| Net Cash Flow | $92.90M |
| Net Cash Flow, Continuing | $81.20M |
| Comprehensive Income/Loss | -$65.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $5.30M |
| Comprehensive Income/Loss Attributable To Parent | -$71.00M |
| Other Comprehensive Income/Loss | -$1.20M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.20M |